Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Medicinal Chemistry   Volumes    Volume 7 
Latest advances in the multiple myeloma drug research: from molecular signaling pathways to small molecules development
Abdulrahman Almehizia, Peng Yang, Lirong Wang, Xiang-Qun Xie
Pages: 105 - 133
Number of pages: 29
Current Trends in Medicinal Chemistry
Volume 7 

Copyright © 2013 Research Trends. All rights reserved

Multiple myeloma (MM) is an uncontrolled differentiation of plasma B cells and the deposits in the bone marrow. MM accounts for 10% of blood cancers and nearly more than 22,000 new cases are diagnosed yearly in the United States. MM is associated with aggressive clinical manifestations including hematological and metabolic diseases. In addition, bone complications are common in more than 60% of cases such as osteoporosis, bone lesions and fractures. Complicated molecular signaling pathogenesis pathways are involved in the MM disease which accounts for the difficult disease control. MM remains an incurable disease despite the recent discovery of novel proteasome inhibitor (Bortezomib). This review addresses the molecular signaling pathways associated with MM progression and survival, and further demonstrates the mechanisms, molecular targets, and the development of current anti-MM agents. Also, we address the recent discoveries in MM molecular targeting as well as the recent discoveries and development of small molecules in patents and/or clinical trials. 
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms